How are you feeling today? Keep up to date on news and stories related to health care here!
If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade Inrebic, if approved, will also be the first once-daily, oral therapy to demonstrate clinically meaningful spleen and symptom response for patients with myelofibrosis where treatment
President Donald Trump speaks after awarding the Presidential Medal of Freedom, the highest civilian honor, to Olympic gold medalist and former University of Iowa wrestling coach Dan Gable in the Oval Office of the White House, Monday, Dec. 7, 2020, in Washington.
A patient is assisted by others to get down from an ambulance at the district government hospital in Eluru, Andhra Pradesh state, India, Tuesday, Dec.8, 2020. Health officials and experts are still baffled by a mysterious illness that has left over 500
PRINCETON, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE: BMY) and Scripps Research today announced that Bristol Myers Squibb has endowed a chair in chemistry at Scripps Research to advance scientific research critical to drug discovery. Scripps Research has named
FILE – In this Wednesday, Sept. 2, 2020 file photo, blood samples from volunteers participating in the last-stage testing of the COVID-19 vaccine by Moderna and the National Institutes wait to be processed in a lab at the University of Miami Miller
Agreement is fundamental element of Bayer’s new Cell & Gene Therapy strategy Bayer to enter CAR T-cell therapy space and expand oncology development pipeline with groundbreaking technology Recognizes the leading position of Atara’s technology platform in allogeneic cell therapy Collaboration will focus
FILE – In this Nov. 15, 2016, file photo, inaugural preparations continue on the West Front of Capitol Hill in Washington, looking at the National Mall and Washington Monument. Health care officials have been warning people for months to avoid parties. But
Nurses at the Royal Free Hospital, London, simulate the administration of the Pfizer vaccine to support staff training ahead of the rollout, in London, Friday Dec. 4, 2020. (Yui Mok/Pool Photo via AP) LONDON (AP) — The coronavirus vaccine developed by
Combined Phase 1b/2 CARTITUDE-1 study presented at ASH 2020 Annual Meeting show 97 percent overall response rate and 12-month progression free survival rate of 77 percent at median follow up of 12.4 months SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”),